Why is Bharat Parenter. falling/rising?

As of 16-Sep, Bharat Parenterals Ltd is experiencing a slight increase in its stock price, currently at 1,354.75, with a change of 0.75 (0.06%) upwards. The stock has shown a consecutive gain over the last two days, rising by 0.2% during this period. However, it has underperformed in the longer term, with a 1-month return of -4.57% and a year-to-date return of -7.70%. Despite declaring positive results in June 2025 after five consecutive negative quarters, including a significant growth in PAT and operating profit, the company faces challenges with weak long-term fundamental strength, as indicated by a -198.31% CAGR growth in operating profits over the last five years and negative operating profits.
In the broader market context, the stock's recent performance contrasts with the benchmark, as the Sensex has gained 1.58% over the past week, while Bharat Parenterals has only seen a marginal decline of -0.03%. This underperformance is further highlighted by the fact that domestic mutual funds hold no stake in the company, suggesting a lack of confidence in its valuation or business prospects. Additionally, the stock's liquidity appears adequate for trading, but a significant drop in delivery volume indicates falling investor participation, which could contribute to its overall weak performance relative to the market.